ImmunoGenesis

1 follower


ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.

Industries

Employees

11-50

Links


Org chart

Collapse
Annemarie Moseley
Acting Chief Medical Officer
Federica Pericle
Chief Scientific Officer
Michael A. Curran
Founder & SAB Head
Federica O’Brien
Strategic Finance Consultant & CFO
Matt H.
Executive Director Of CMC And Quality

Board & advisors

Lawrence Fong
Scientific Advisor
David S. Hong
Scientific Advisor
Taha Merghoub
Scientific Advisor
Ingunn Stromnes
Scientific Advisor
Xingxing Zang
Scientific Advisor